1 has been uncovered over the past few years.
The CCN family comprises both positive and negative regulators sharing a common multimodular organisation. New members of the CCN family have been described recently. More are to come.
The chicken CEF10 and homologue murine cyr61 genes were first identified as immediate early genes induced by the pp60 v-src oncogene and serum growth factors, respectively.
2 3 The CYR61 protein was shown to promote cell adhesion, migration, and proliferation, probably through potentiating platelet derived growth factor (PDGF) and basic fibroblast growth factor (bFGF) activities. 4 Human ctgf was also identified as an immediate early gene encoding a connective tissue growth factor (CTGF) 5 showing mitogenic activity for human umbilac vein endothelial cells (HUVECs) and fibroblasts in culture. 6 The nov gene was initially characterised as an integration site for the myeloblastosis associated virus (MAV), 7 which induces kidney tumours that represent a unique model of the Wilms's tumour. 8 The expression of the nov gene was found to be altered either positively or negatively in human and animal tumours. 9 10 The murine Elm1 gene (expressed in low metastatic cells) was reported to be expressed in low metastatic but not in high metastatic K-1735 mouse melanoma cells. It was found to exhibit cell growth inhibitory properties and to suppress the tumorigenic potential of mouse melanoma cells.
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Murine rCop-1 gene expression was completely abolished after transformation, and retroviral driven expression of rCop-1 had a dramatic cytotoxic eVect on transformed cells, but not on untransformed counterparts. 12 More recently, three genes involved in the Wnt1 signalling pathway (WISP-1, WISP-2, WISP-3) were shown to be highly related to the CCN family of genes. 13 The WISP-1 and WISP-2 genes are homologous to Elm1, and rCop-1, respectively.
A novel regulator of osteoblast functions (CTGF-L) was also found to be homologous to CTGF. 14 The presence of an insulin-like growth factor binding protein (IGFBP)-like motif at the C-terminus of NOVH and the extensive homology of nov, ctgf, cyr61, Elm1, rCOP-1, and IGFBP3 genes at the 5' end raised the possibility that the proteins might be acting in the IGF signalling pathway. The only evidence is that CTGF 15 and NOV 16 bind IGF in vitro with a 100-1000 times lower aYnity than authentic IGFBPs. Because IGF binding to NOV was not observed under standard ligand blotting assay conditions, 17 this low aYnity binding for IGF remains controversial. No published data suggest binding of CYR61 to IGF. It will be interesting to establish whether the CCN proteins share common signalling activities with IGFBPs through IGF independent pathways, as recently reviewed for IGFBP-3. 18 Two motifs sharing identity with the Von Willebrand type C (VWC) domain, probably responsible for oligomerisation, and with the thrombospondin type 1 (TSP1) repeat, responsible for interactions with extracellular matrix proteins, have been recognised in the diVerent members of the CCN family. Although the biological activity of these motifs remains to be established, their conservation in all members of the CCN family argues for their biochemical or structural importance.
The C-terminal module (CT) of the CCN proteins, which was proposed to represent a dimerisation domain, 1 contains a cystine knot motif present and involved in the dimerisation of several growth factors, such as nerve growth factor (NGF), transforming growth factor 2 (TGF-2), and platelet derived growth factor BB (PB-GFBB). It has been established that the C-terminal domain promotes interactions of the nov protein with fibulin 1C and CTGF. 19 The absence of this motif in the rCOP-1/CTGF-L/WISP-2 protein 12-14 might be important.
The multimodular structure of NOV and other CCN proteins raises interesting questions as to the contribution of each individual module to the biological properties of the full length proteins. It is possible that either the biochemical functions of the IGFBP, VWC, TSP, and CT modules contained in these proteins are indeed conserved and sum up in the full length protein, or the presence of each module confers on the whole protein specific biological function(s), which may substitute or add upon those of individual modules.
The bulk of results available to date show that the CCN proteins are involved in the regulation of cell adhesion, migration, proliferation, and survival. The number of studies concerning the role of these proteins in normal key biological processes and in a variety of pathologies is increasing at a steady pace.
Undoubtedly, deciphering the functions of the CCN proteins will result in important progress in understanding the molecular basis of cell growth control and diVerentiation in normal and pathological conditions. 
